|
SWE 2011
COI 1.54 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
-
7/1/2022
Laboklin
Elbows
normal
-
21/1/2013
2023-11-06 Index:106
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
28/8/2013
Laboklin
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
21/1/2013
2023-11-06 Index: 91
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
-
6/2/2013
Optigen
|
FIN 2001
COI 1.70 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
|||
SWE 2009
COI 1.49 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Year of death:
2021
|
FIN 2002
COI 1.60 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/mut (carrier)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2013
|
||
FIN 2005
COI 2.95 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
|
|||
SWE 2017
COI 0.78 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
|
|
|||
|
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Raiddokas Samos
|
17 May 2011 | N/N (clear) | normal | N/N (clear) | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | N/mut (carrier) | ||||
Degenerative myelopathy (DM):
N/N (clear)
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA):
N/mut (carrier)
|
||||||||||
Lapprott's Embla
|
27 Jul 2017 | normal | N/N (clear) | N/N (clear) | ||||||
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Lapprott's Aliina
|
6 May 2021 | |||||||||
Lapprott's Carhu
|
6 May 2021 | |||||||||
Lapprott's Ilona
|
6 May 2021 | |||||||||
Lapprott's Nera
|
6 May 2021 | N/N (clear) | Mild / C1 / 9-12 / C / 26-35 | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Lapprott's Riina
|
6 May 2021 | N/N (clear) | N/N (clear) | N/mut (carrier) | ||||||
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/mut (carrier)
|
||||||||||
Half siblings (sire) | ||||||||||
Lappelands Nallenaama
|
18 Dec 2016 | |||||||||
Lappelands Nallukka
|
18 Dec 2016 | |||||||||
Lappelands Napero
|
18 Dec 2016 | |||||||||
Lappelands Nätti
|
18 Dec 2016 | |||||||||
Lappelands Neiti
|
18 Dec 2016 | |||||||||
Lappelands Nero
|
18 Dec 2016 | normal | N/N (clear) | Moderate / D2 / 19-30 / D / 36-50 | N/N (clear) | |||||
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Moderate / D2 / 19-30 / D / 36-50
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Lappelands Neropatti
|
18 Dec 2016 | |||||||||
Lappelands Nuppu
|
18 Dec 2016 | |||||||||
Sarakkas Dálvi Giron
|
18 Feb 2017 | |||||||||
Sarakkas Dálvi Nasti
|
18 Feb 2017 | |||||||||
Sarakkas Dálvi Pirak
|
18 Feb 2017 | |||||||||
Sarakkas Dálvi Vaimo
|
18 Feb 2017 | |||||||||
Half siblings (dam) | ||||||||||
Lapprott's Bibbi
|
11 Apr 2020 | |||||||||
Lapprott's Bobbo
|
11 Apr 2020 | |||||||||
Lapprott's Diddi
|
11 Apr 2020 | |||||||||
Lapprott's Doddo
|
11 Apr 2020 | |||||||||
Offspring |